Cancer Research CR Mantle  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Locke, M.
Right arrow Articles by Mackenzie, I. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Locke, M.
Right arrow Articles by Mackenzie, I. C.
[Cancer Research 65, 8944-8950, October 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Retention of Intrinsic Stem Cell Hierarchies in Carcinoma-Derived Cell Lines

Matthew Locke, Matthew Heywood, Stuart Fawell and Ian C. Mackenzie

Institute for Cell and Molecular Science, Queen Mary University of London, Whitechapel, London, United Kingdom

Requests for reprints: Ian C. Mackenzie, Institute for Cell and Molecular Science, Queen Mary University of London, 2 Newark Street, Whitechapel, London E1 2AT, United Kingdom. Phone: 0207-882-7159; Fax: 0207-882-7171; E-mail: i.c.mackenzie{at}qmul.ac.uk.

Recent work indicates that the growth and behavior of cancers are ultimately determined by a small subpopulation of malignant stem cells and that information about the properties of these cells is urgently needed to enable their targeting for therapeutic elimination. A key feature of normal stem cells is their asymmetrical division, the mechanism that allows stem cell self-renewal while producing hierarchies of amplifying and differentiating cells that form the bulk of the tissue. Most cancer deaths result from epithelial malignancies, but the extent to which the hierarchical proliferative stem and amplifying cell patterns of normal epithelia are actually retained in epithelial malignancies has been unclear. Here we show that even cell lines generated from carcinomas consistently produce in vitro colony patterns unexpectedly similar to those produced by the stem and amplifying cells of normal epithelia. From the differing types of colony morphologies formed, it is possible to predict both the growth potential of their constituent cells and their patterns of macromolecular expression. Maintenance of a subpopulation of stem cells during passage of cell lines indicates that the key stem cell property of asymmetrical division persists but is shifted towards enhanced stem cell self-renewal. The presence of malignant epithelial stem cells in vivo has been shown by serial transplantation of primary cancer cells and the present observations indicate that stem cell patterns are robust and persist even in cell lines. An understanding of this behavior should facilitate studies directed towards the molecular or pharmacologic manipulation of malignant stem cell survival.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
S. Nurmenniemi, T. Sinikumpu, I. Alahuhta, S. Salo, M. Sutinen, M. Santala, J. Risteli, P. Nyberg, and T. Salo
A Novel Organotypic Model Mimics the Tumor Microenvironment
Am. J. Pathol., September 1, 2009; 175(3): 1281 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Veterinary PathologyHome page
J. E. Trosko
Review Paper: Cancer Stem Cells and Cancer Nonstem Cells: From Adult Stem Cells or from Reprogramming of Differentiated Somatic Cells
Veterinary Pathology, March 1, 2009; 46(2): 176 - 193.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Bhattacharya, J. Kwon, B. Ali, E. Wang, S. Patra, V. Shridhar, and P. Mukherjee
Role of Hedgehog Signaling in Ovarian Cancer
Clin. Cancer Res., December 1, 2008; 14(23): 7659 - 7666.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S.-H. Chiou, C.-C. Yu, C.-Y. Huang, S.-C. Lin, C.-J. Liu, T.-H. Tsai, S.-H. Chou, C.-S. Chien, H.-H. Ku, and J.-F. Lo
Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma
Clin. Cancer Res., July 1, 2008; 14(13): 4085 - 4095.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Zhang, C. Balch, M. W. Chan, H.-C. Lai, D. Matei, J. M. Schilder, P. S. Yan, T. H-M. Huang, and K. P. Nephew
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Cancer Res., June 1, 2008; 68(11): 4311 - 4320.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. B. Horwitz, W. W. Dye, J. C. Harrell, P. Kabos, and C. A. Sartorius
Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts
PNAS, April 15, 2008; 105(15): 5774 - 5779.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Engelmann, H. Shen, and O. J. Finn
MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1
Cancer Res., April 1, 2008; 68(7): 2419 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Li, X. Chen, T. Calhoun-Davis, K. Claypool, and D. G. Tang
PC3 Human Prostate Carcinoma Cell Holoclones Contain Self-renewing Tumor-Initiating Cells
Cancer Res., March 15, 2008; 68(6): 1820 - 1825.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Tang, N. Yoo, M. Vu, M. Mamura, J.-S. Nam, A. Ooshima, Z. Du, P.-Y. Desprez, M. R. Anver, A. M. Michalowska, et al.
Transforming Growth Factor-{beta} Can Suppress Tumorigenesis through Effects on the Putative Cancer Stem or Early Progenitor Cell and Committed Progeny in a Breast Cancer Xenograft Model
Cancer Res., September 15, 2007; 67(18): 8643 - 8652.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Jin, S. Park, D. Z. Ewton, and E. Friedman
The Survival Kinase Mirk/Dyrk1B Is a Downstream Effector of Oncogenic K-ras in Pancreatic Cancer
Cancer Res., August 1, 2007; 67(15): 7247 - 7255.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. Villadsen, A. J. Fridriksdottir, L. Ronnov-Jessen, T. Gudjonsson, F. Rank, M. A. LaBarge, M. J. Bissell, and O. W. Petersen
Evidence for a stem cell hierarchy in the adult human breast
J. Cell Biol., April 9, 2007; 177(1): 87 - 101.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.